← Eichor
Condition: Monocytes Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Monocytes

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Specifying the Anti-inflammatory Effects of Ziltivekimab
Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06263244Cladribine Venetoclax in Monocytic AML
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT06232655Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation
Phase N/A · 2 location(s) · Koç University · NCT06957145Prediction of Mortality and Morbidity After Hip Fracture Using Monocyte Distribution Width (MDW)
Phase N/A · 1 location(s) · National and Kapodistrian University of Athens · NCT07350785OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NA · 1 location(s) · Gynaecologisch Oncologisch Centrum Zuid · NCT06611072Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal Infection
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT07130799Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Phase N/A · 1 location(s) · University of Michigan · NCT06007404Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
Phase N/A · 1 location(s) · UConn Health · NCT04321512Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia
Phase 2 · 3 location(s) · Chinese PLA General Hospital · NCT07512700OR6A2 on Monocytes and Cardiovascular Outcomes in Myocardial Ischemia-Reperfusion Injury
Phase N/A · 1 location(s) · Southeast University, China · NCT07100457Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
Phase 3 · 9 location(s) · Hospices Civils de Lyon · NCT05843786Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Survival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants
NA · 2 location(s) · Hospices Civils de Lyon · NCT04697095Impact of Vascular Calcification and CASR Expression by Monocytes in Septic Shock
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06853340Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myel
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT03970096Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
Phase 2 · 1 location(s) · University of Washington · NCT03737955Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NA · 3 location(s) · University Hospital, Angers · NCT06361641Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Phase N/A · 1 location(s) · University of Ulm · NCT03044223Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07180992MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT07597122211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Le
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03670966Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
EARLY_Phase 1 · 1 location(s) · Omar Aljitawi · NCT03964506MoMa Signature During Granulomatosis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05916638Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT06694558Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT05985447Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06462664Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment
Phase 2 · 2 location(s) · OHSU Knight Cancer Institute · NCT06504459A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Phase 1 · 7 location(s) · Solu Therapeutics, Inc · NCT06950034Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Ne
Phase 2 · 1 location(s) · University of Washington · NCT04282187Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
Phase 1 · 1 location(s) · University of Colorado, Denver · NCT06429449
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.